Event Brief
Mar 27, 2026 at 8:01 AM ET
Novartis Acquires Excellergy for $2 Billion
By The BriefBrief
Novartis invests in Excellergy to enhance allergy treatment options.
WHO: Novartis
WHAT: Acquisition of Excellergy
WHEN: Mar 27, 2026 at 7:43 AM ET
WHERE: Switzerland
WHY: To bet on a next-generation allergy treatment.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21414 of 21414
Same format. Every time.
Continue reading — sign in or create a free account with
